Galectin Therapeutics Inc (GALT) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Galectin Therapeutics Inc   (NASDAQ: GALT)

Galectin Therapeutics Inc

Officers & Directors


Executives:

- Joel Lewis (Chief Executive Officer, President, and Director)

- Jack W. Callicutt (Chief Financial Officer)

Board of Directors:

- Richard E. Uihlein (Chairman of the Board)

- Benjamin S. Carson, Sr., M.D. (Director)

- Elissa J. Schwartz, Ph.D. (Director)

- Harold H. Shlevin, Ph.D. (Director)

- Kary Eldred (Director)

- Gilbert S. Omenn, M.D., Ph.D. (Director)

- Gilbert F. Amelio, Ph.D. (Director)

- Richard A. Zordani (Director)

- Marc Rubin, M.D. (Director)

- Kevin D. Freeman (Director) ,

Galectin Therapeutics Inc currently has 9 employees.






GALT Management Effectiveness GALT Revenue per Employee GALT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.